Kyogo Itoh

Kyogo Itoh

UNVERIFIED PROFILE

Are you Kyogo Itoh?   Register this Author

Register author
Kyogo Itoh

Kyogo Itoh

Publications by authors named "Kyogo Itoh"

Are you Kyogo Itoh?   Register this Author

100Publications

2119Reads

21Profile Views

Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma.

Jpn J Clin Oncol 2019 Sep;49(9):870-876

Ci3-Cluster of Individualized Immune Intervention, Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyz068DOI Listing
September 2019

Immunological consequences following splenectomy in patients with liver cirrhosis.

Exp Ther Med 2019 Jul 3;18(1):848-856. Epub 2019 Jun 3.

Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/etm.2019.7640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591499PMC
July 2019

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Authors:
Franck Pagès Bernhard Mlecnik Florence Marliot Gabriela Bindea Fang-Shu Ou Carlo Bifulco Alessandro Lugli Inti Zlobec Tilman T Rau Martin D Berger Iris D Nagtegaal Elisa Vink-Börger Arndt Hartmann Carol Geppert Julie Kolwelter Susanne Merkel Robert Grützmann Marc Van den Eynde Anne Jouret-Mourin Alex Kartheuser Daniel Léonard Christophe Remue Julia Y Wang Prashant Bavi Michael H A Roehrl Pamela S Ohashi Linh T Nguyen SeongJun Han Heather L MacGregor Sara Hafezi-Bakhtiari Bradly G Wouters Giuseppe V Masucci Emilia K Andersson Eva Zavadova Michal Vocka Jan Spacek Lubos Petruzelka Bohuslav Konopasek Pavel Dundr Helena Skalova Kristyna Nemejcova Gerardo Botti Fabiana Tatangelo Paolo Delrio Gennaro Ciliberto Michele Maio Luigi Laghi Fabio Grizzi Tessa Fredriksen Bénédicte Buttard Mihaela Angelova Angela Vasaturo Pauline Maby Sarah E Church Helen K Angell Lucie Lafontaine Daniela Bruni Carine El Sissy Nacilla Haicheur Amos Kirilovsky Anne Berger Christine Lagorce Jeffrey P Meyers Christopher Paustian Zipei Feng Carmen Ballesteros-Merino Jeroen Dijkstra Carlijn van de Water Shannon van Lent-van Vliet Nikki Knijn Ana-Maria Mușină Dragos-Viorel Scripcariu Boryana Popivanova Mingli Xu Tomonobu Fujita Shoichi Hazama Nobuaki Suzuki Hiroaki Nagano Kiyotaka Okuno Toshihiko Torigoe Noriyuki Sato Tomohisa Furuhata Ichiro Takemasa Kyogo Itoh Prabhu S Patel Hemangini H Vora Birva Shah Jayendrakumar B Patel Kruti N Rajvik Shashank J Pandya Shilin N Shukla Yili Wang Guanjun Zhang Yutaka Kawakami Francesco M Marincola Paolo A Ascierto Daniel J Sargent Bernard A Fox Jérôme Galon

Lancet 2018 05 10;391(10135):2128-2139. Epub 2018 May 10.

INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)30789-XDOI Listing
May 2018

Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.

J Immunol Res 2017 27;2017:1423683. Epub 2017 Apr 27.

Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/1423683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426075PMC
March 2018

Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase.

Cancer Sci 2018 Mar 28;109(3):611-617. Epub 2018 Feb 28.

Cancer Vaccine Center, Kurume University, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834778PMC
March 2018

Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine.

Cancer Sci 2017 Dec 3;108(12):2326-2332. Epub 2017 Oct 3.

Division of Clinical Research, Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715291PMC
December 2017

Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.

Clin Lung Cancer 2017 11 24;18(6):e385-e394. Epub 2017 Mar 24.

Cancer Vaccine Center, Kurume University, Kurume, Japan; Kanagawa Cancer Center Research Institute, Yokohama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.03.011DOI Listing
November 2017

Clinical development of immunotherapy for prostate cancer.

Int J Urol 2017 09 21;24(9):675-680. Epub 2017 Jun 21.

Cancer Vaccine Center, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/iju.13397DOI Listing
September 2017

Single nucleotide polymorphisms of the haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccination.

Oncol Lett 2017 Feb 7;13(2):993-999. Epub 2016 Dec 7.

Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.5467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351398PMC
February 2017

Prospect and progress of personalized peptide vaccinations for advanced cancers.

Expert Opin Biol Ther 2016 21;16(5):689-98. Epub 2016 Mar 21.

b Cancer Vaccine Center , Kurume University , Kurume , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2016.1161752DOI Listing
October 2016

Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.

Cancer Immunol Immunother 2016 10 22;65(10):1223-31. Epub 2016 Aug 22.

Cancer Vaccine Center, Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1887-5DOI Listing
October 2016

[Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment].

Gan To Kagaku Ryoho 2016 Oct;43(10):1249-1251

Dept. of Surgery Kurume University School of Medicine.

View Article

Download full-text PDF

Source
October 2016

Immunotherapy in prostate cancer: challenges and opportunities.

Immunotherapy 2016 7;8(1):69-77. Epub 2015 Dec 7.

Cancer Vaccine Center, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.15.101DOI Listing
June 2016

Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients.

Cancer Immunol Immunother 2015 Dec 1;64(12):1565-73. Epub 2015 Oct 1.

Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, 6-10-1 Hakozaki Higashi-Ku, Fukuoka, 812-8581, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-015-1756-7DOI Listing
December 2015

[Pretreatment and Posttreatment Evaluations of Circulating Tumor Cells(CTC)in Patients with Metastatic Breast Cancer].

Gan To Kagaku Ryoho 2015 Oct;42(10):1237-9

Dept. of Surgery, Kurume University School of Medicine.

View Article

Download full-text PDF

Source
October 2015

Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy.

Cancer Sci 2015 Sep 22;106(9):1111-7. Epub 2015 Jul 22.

Department of Obstetrics and Gynecology, School of Medicine, Kurume University, Kurume.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12729DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582979PMC
September 2015

Personalized peptide vaccination for advanced colorectal cancer.

Oncoimmunology 2015 May 3;4(5):e1005512. Epub 2015 Feb 3.

Cancer Vaccine Center; Kurume University ; Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1005512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485709PMC
May 2015

Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine.

Int J Oncol 2015 Apr 23;46(4):1699-709. Epub 2015 Jan 23.

Laboratory of Hematology and Oncology, Graduate School of Health Sciences, Niigata University, Niigata 951‑8518, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2015.2846DOI Listing
April 2015

Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.

Cancer Immunol Immunother 2015 Apr 7;64(4):493-505. Epub 2015 Feb 7.

Division of Clinical Research, Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-015-1660-1DOI Listing
April 2015

Reduced expression of erythropoietin-producing hepatocyte B6 receptor tyrosine kinase in prostate cancer.

Oncol Lett 2015 Apr 3;9(4):1672-1676. Epub 2015 Feb 3.

Cancer Vaccine Center, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.2925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356330PMC
April 2015

Personalized peptide vaccine for treatment of advanced cancer.

Curr Med Chem 2014 ;21(21):2332-45

Department of Immunology and Immunotherapy, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/0929867321666140205132936DOI Listing
February 2015

Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancer.

Cancer Immunol Res 2014 Dec 28;2(12):1154-62. Epub 2014 Oct 28.

Cancer Vaccine Center, Kurume University, Kurume, Japan. Department of Immunology and Immunotherapy, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0035DOI Listing
December 2014

PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer.

Cancer Sci 2014 Oct 23;105(10):1229-35. Epub 2014 Sep 23.

Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462362PMC
October 2014

Genetic factors associated with serum haptoglobin level in a Japanese population.

Clin Chim Acta 2014 Jun 12;433:54-7. Epub 2014 Mar 12.

Department of Forensic Medicine and Human Genetics, Kurume University School of Medicine, Kurume 830-0011, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2014.02.029DOI Listing
June 2014

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.

BMC Cancer 2013 Dec 30;13:613. Epub 2013 Dec 30.

Clinical Research Division of the Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882108PMC
December 2013

Haptoglobin proved a prognostic biomarker in peripheral blood of patients with personalized peptide vaccinations for advanced castration-resistant prostate cancer.

Biosci Biotechnol Biochem 2013 7;77(4):766-70. Epub 2013 Apr 7.

Graduate School of Systems Life Sciences, Department of Bioscience and Biotechnology, Kyushu University, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1271/bbb.120893DOI Listing
November 2013

A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients.

Oncol Rep 2013 Sep 20;30(3):1094-100. Epub 2013 Jun 20.

Department of Immunology and Immunotherapy, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2013.2556DOI Listing
September 2013

Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein.

Mol Immunol 2013 Jul 27;54(3-4):465-71. Epub 2013 Feb 27.

Ludwig Institute for Cancer Research Melbourne-Austin Branch, Heidelberg, VIC 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2013.01.014DOI Listing
July 2013

Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.

Cancer Immunol Immunother 2013 May 30;62(5):919-29. Epub 2012 Nov 30.

Department of Urology, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-012-1379-1DOI Listing
May 2013

Current status of immunotherapy for the treatment of biliary tract cancer.

Hum Vaccin Immunother 2013 May 1;9(5):1069-72. Epub 2013 Feb 1.

Department of Surgery; Kurume University School of Medicine; Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.23844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899141PMC
May 2013

Next-generation peptide vaccines for advanced cancer.

Cancer Sci 2013 Jan 4;104(1):15-21. Epub 2012 Dec 4.

Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12050DOI Listing
January 2013

[Personalized peptide vaccination].

Nihon Rinsho 2012 Dec;70(12):2118-23

Department of Immunology and Immunotherapy, Kurume University School of Medicine.

View Article

Download full-text PDF

Source
December 2012

In vitro induction of specific CD8+ T lymphocytes by tumor-associated antigenic peptides in patients with oral squamous cell carcinoma.

Cancer Lett 2012 Sep 22;322(1):86-91. Epub 2012 Feb 22.

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Higashi-ku, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2012.02.016DOI Listing
September 2012

Personalized peptide vaccination: a novel immunotherapeutic approach for advanced cancer.

Hum Vaccin Immunother 2012 Sep 16;8(9):1309-13. Epub 2012 Aug 16.

Department of Immunology and Immunotherapy, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.20988DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579913PMC
September 2012

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.

Prostate 2012 Jun 19;72(8):834-45. Epub 2011 Sep 19.

Division of Clinical Research of the Research Center for Innovative Cancer Therapy, Kurume University School ofMedicine, 67 Asahi-machi, Kurume 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21485DOI Listing
June 2012

Recent advances in active specific cancer vaccine treatment for colorectal cancer.

Curr Pharm Biotechnol 2012 Jun;13(8):1439-45

Department of Surgery, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-sayama 589- 8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138920112800784998DOI Listing
June 2012

Personalized peptide vaccination in patients with refractory non-small cell lung cancer.

Int J Oncol 2012 May 1;40(5):1492-500. Epub 2012 Feb 1.

Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2012.1351DOI Listing
May 2012

[Current status and prospects of cancer vaccine therapy].

Nihon Rinsho 2011 Sep;69(9):1651-6

Krume University School of Medicine.

View Article

Download full-text PDF

Source
September 2011

[Current status and future perspective of cancer vaccine development].

Gan To Kagaku Ryoho 2011 Apr;38(4):503-8

Dept. of Immunology and Immunotherapy, Kurume University School of Medicine, Japan.

View Article

Download full-text PDF

Source
April 2011

Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 cases.

Oncol Rep 2011 Jan;25(1):57-62

Department of Immunology and Immunotherapy, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
January 2011

Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme.

J Clin Oncol 2011 Jan 13;29(3):337-44. Epub 2010 Dec 13.

Department of Neurosurgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.29.7499DOI Listing
January 2011

Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.

Cancer Sci 2010 Oct 30;101(10):2110-4. Epub 2010 Jul 30.

Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2010.01653.xDOI Listing
October 2010

Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines.

Eur J Cancer 2010 Jun 21;46(9):1514-9. Epub 2010 Apr 21.

Department of Immunology and Immunotherapy, Kurume University School of Medicine, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.03.013DOI Listing
June 2010

Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer.

Cancer Sci 2010 Mar 7;101(3):601-8. Epub 2009 Dec 7.

Department of Urology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2009.01459.xDOI Listing
March 2010

An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.

Cancer Immunol Immunother 2009 Nov 28;58(11):1877-85. Epub 2009 Mar 28.

Department of Immunology and Immunotherapy, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0699-2DOI Listing
November 2009

Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.

Cancer Immunol Immunother 2009 Nov 26;58(11):1843-52. Epub 2009 Apr 26.

Department of Surgery, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0695-6DOI Listing
November 2009

Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients.

Cancer Sci 2009 Nov 23;100(11):2167-74. Epub 2009 Jul 23.

Immunology and Immunotherapy, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2009.01298.xDOI Listing
November 2009

Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.

Lung Cancer 2009 Jun 1;64(3):326-33. Epub 2008 Nov 1.

Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.09.002DOI Listing
June 2009

Recent advances in cancer vaccines: an overview.

Jpn J Clin Oncol 2009 Feb 16;39(2):73-80. Epub 2008 Nov 16.

Department of Immunology and Immunotherapy, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyn132DOI Listing
February 2009

A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patients.

Asian Pac J Allergy Immunol 2008 Jun-Sep;26(2-3):97-104

Department of Immunology, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
February 2009

Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms.

Asian J Androl 2008 Sep 20;10(5):777-85. Epub 2007 Dec 20.

Department of Urology, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1745-7262.2008.00361.xDOI Listing
September 2008

Detection of IgE antibody specific to a hepatitis C virus-derived peptide being recognized by cellular immunity in patients with HCV infection.

Viral Immunol 2008 Sep;21(3):365-9

Department of Immunology, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/vim.2008.0020DOI Listing
September 2008

Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients.

Oncol Rep 2008 May;19(5):1277-83

Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Fukuoka 830-0011, Japan.

View Article

Download full-text PDF

Source
May 2008

HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma.

Oncol Rep 2007 Dec;18(6):1463-8

Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
December 2007